Los Angeles Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Los Angeles Capital Management LLC

$22.3 Billion
Q1 2025

A detailed history of Los Angeles Capital Management LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 53,120 shares of PCRX stock, worth $1.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

53,120

Previous 76,087 30.19%

Holding current value

$1.37 Million

Previous $1.43 Million 7.89%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$18.33 - $27.25 $420,985 - $625,850	-22,967 Reduced 30.19%	53,120 $1.32 Million
Q4 2024 Feb 04, 2025	SELL	$15.3 - $20.33 $1.07 Million - $1.42 Million	-69,843 Reduced 47.86%	76,087 $1.43 Million
Q3 2024 Nov 04, 2024	BUY	$11.7 - $28.46 $1.54 Million - $3.75 Million	131,934 Added 942.66%	145,930 $2.2 Million
Q2 2024 Aug 05, 2024	SELL	$25.5 - $31.51 $285,396 - $352,659	-11,192 Reduced 44.43%	13,996 $400,000
Q1 2024 Apr 05, 2024	BUY	$27.7 - $35.48 $697,707 - $893,670	25,188 New	25,188 $735,000
Q3 2023 Nov 06, 2023	BUY	$30.68 - $40.09 $4,264 - $5,572	139 Added 0.43%	32,270 $990,000
Q2 2023 Aug 03, 2023	BUY	$36.12 - $47.5 $1.16 Million - $1.53 Million	32,131 New	32,131 $1.29 Million
Q2 2022 Aug 05, 2022	SELL	$51.49 - $81.64 $117,345 - $186,057	-2,279 Reduced 22.17%	8,002 $467,000
Q1 2022 May 06, 2022	BUY	$60.03 - $76.49 $43,881 - $55,914	731 Added 7.65%	10,281 $785,000
Q4 2021 Feb 03, 2022	SELL	$47.97 - $62.21 $2,254 - $2,923	-47 Reduced 0.49%	9,550 $575,000
Q3 2021 Nov 08, 2021	SELL	$54.64 - $61.3 $23,222 - $26,052	-425 Reduced 4.24%	9,597 $537,000
Q2 2021 Aug 05, 2021	SELL	$59.18 - $69.99 $192,630 - $227,817	-3,255 Reduced 24.52%	10,022 $608,000
Q1 2021 May 05, 2021	SELL	$59.31 - $78.82 $640,014 - $850,546	-10,791 Reduced 44.84%	13,277 $930,000
Q4 2020 Feb 04, 2021	BUY	$50.47 - $66.26 $13,879 - $18,221	275 Added 1.16%	24,068 $1.44 Million
Q3 2020 Nov 02, 2020	SELL	$51.97 - $63.0 $1.09 Million - $1.33 Million	-21,054 Reduced 46.95%	23,793 $1.43 Million
Q2 2020 Aug 05, 2020	BUY	$30.8 - $52.47 $14,876 - $25,343	483 Added 1.09%	44,847 $2.35 Million
Q1 2020 May 04, 2020	BUY	$28.4 - $50.7 $1.13 Million - $2.01 Million	39,725 Added 856.33%	44,364 $1.49 Million
Q4 2019 Feb 07, 2020	SELL	$36.31 - $46.83 $238,774 - $307,954	-6,576 Reduced 58.64%	4,639 $210,000
Q3 2019 Nov 07, 2019	SELL	$35.66 - $44.99 $333,242 - $420,431	-9,345 Reduced 45.45%	11,215 $427,000
Q2 2019 Jul 29, 2019	SELL	$36.57 - $47.97 $148,474 - $194,758	-4,060 Reduced 16.49%	20,560 $894,000
Q1 2019 Apr 25, 2019	BUY	$36.47 - $42.17 $439,828 - $508,570	12,060 Added 96.02%	24,620 $937,000
Q4 2018 Feb 11, 2019	BUY	$41.31 - $52.16 $105,133 - $132,747	2,545 Added 25.41%	12,560 $540,000
Q3 2018 Nov 05, 2018	BUY	$32.85 - $52.0 $8,869 - $14,040	270 Added 2.77%	10,015 $492,000
Q2 2018 Jul 31, 2018	BUY	$27.5 - $39.8 $267,987 - $387,851	9,745 New	9,745 $312,000

Others Institutions Holding PCRX

# of Institutions

254

Shares Held

51.1M

Call Options Held

157K

Put Options Held

139K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.18B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Pacira Bio Sciences, Inc. Transaction History